Soleno Therapeutics, Inc. (SLNO), a developer of novel therapeutics for the treatment of rare diseases, said on Thursday that it has appointed Jennifer Fulk as Chief Financial Officer.
She will succeed James Mackaness, who will retire from the company by the end of the first quarter.
Fulk served as Chief Operating Officer and Chief Financial Officer of 120Water, Inc. from September 2024 through October 2025.
Previously, she served as Chief Financial Officer of Talkspace, Inc., a virtual behavioral healthcare company, from July 2021 to May 2024.
Fulk also spent over 15 years at Eli Lilly and Company in various finance executive roles, including Chief Financial Officer of U.S. Bio-Medicines.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.